Cellid
Chemicals & Related Products · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Seoul, Seoul-t'ukpyolsi, South KoreaPhone Number
+82 232857860Website
www.cellid.co.krRevenue
$18 MillionIndustry
ZI Rank: 1
About Cellid
Cellid Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cellid your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cellid recently announced quarterly report
Click to see if Cellid had a recent Job posting/layoffs
Check out if Cellid is spiking on competitors!
Product Launch: Get notified when Cellid launches new products
Congratulate Masked Content for being promoted to Masked Content at Cellid
Website visits: Recent activity has been detected on your website
Check if Cellid has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cellid has new funding data
Cellid, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Cellid as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cellid is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cellid is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cellid.
Cellid Tech Stack
A closer look at the technologies used by Cellid
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellid
CELLID recently finished the administration of subjects in Part C (Phase I) trial of its AdCLD-CoV19-1 COVID-19 vaccine, and shall submit IND for the next stage of clinical trials to the Ministry of Food and Drug Safety, Republic of Korea during Oct. 2021 and has plans to submit interim report of Global clinical trials & EUL on 1 st & 2 nd quarter... Read More
